Sign In
Buy WBA
$11.98
+0 (+0%)
At Close: Nov 26, 2025
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions
09:46am, Thursday, 17'th Apr 2025
Walgreens Boots Alliance (WBA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Walgreens: Acquisition Is The Best-Case Scenario For The Company
03:43pm, Tuesday, 15'th Apr 2025
Walgreens Boots Alliance faces significant challenges, including rising inflation, heavy competition, and decreasing profitability, making it a Hold if the acquisition by Sycamore goes through. The co
Walgreens Comeback? Private Equity Circling for a Buyout
07:38am, Sunday, 13'th Apr 2025
Sometimes, the stock market gives investors the opportunity to play in the corporate leagues, where deals are made not on the stock chart or tape but at the negotiating table when markets are closed a
Down 89%, Should You Buy the Dip on Walgreens Boots Alliance?
10:00am, Saturday, 12'th Apr 2025
Walgreens Boots Alliance (WBA 0.75%) is in a pending acquisition with Sycamore Partners, a private equity firm, to take the struggling pharmacy chain private. It could end a years-long struggle for th
Seeking Income? 3 High Yield Stocks Worth a Look
06:00pm, Thursday, 10'th Apr 2025
Everybody loves dividends, as they provide a passive income stream and more than one way to reap a return from an investment. Dividend-paying stocks are generally less volatile by nature, another posi
Walgreens Boots Alliance: Last Change To Buy
11:47am, Thursday, 10'th Apr 2025
Walgreens Boots Alliance faces significant challenges, including declining margins, rising labor costs, and fierce competition from online pharmacies and retail giants like Amazon and Walmart. The pro
Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down
08:30am, Wednesday, 09'th Apr 2025
WBA delivers better-than-expected earnings and revenues in the second quarter of fiscal 2025.
WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company
04:51pm, Tuesday, 08'th Apr 2025
Shares in Walgreens Boots Alliance (Nasdaq: WBA) are trading slightly higher this morning after the company reported its Q2 2025 earnings. The results, which beat on earnings and revenue, are notable
Walgreens Continues Turnaround Efforts Ahead of Planned Acquisition by Private Equity Firm
01:30pm, Tuesday, 08'th Apr 2025
Walgreens Boots Alliance (WBA) saw its second-quarter fiscal 2025 sales increase and its operating loss drop as it continues its turnaround plan and prepares to be acquired. The retail pharmacy compan
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
12:30pm, Tuesday, 08'th Apr 2025
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its to
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
12:11pm, Tuesday, 08'th Apr 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Tuesday.
Walgreens (WBA) Reports Q2 Earnings: What Key Metrics Have to Say
10:30am, Tuesday, 08'th Apr 2025
The headline numbers for Walgreens (WBA) give insight into how the company performed in the quarter ended February 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Walgreens Boots Alliance (WBA) Beats Q2 Earnings and Revenue Estimates
09:15am, Tuesday, 08'th Apr 2025
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $1.20 per share a year ago.
Walgreens tops estimates as drugstore chain cuts costs, prepares to go private
08:47am, Tuesday, 08'th Apr 2025
CNBC's Becky Quick reports on the company's quarterly earnings results.
Walgreens Sales Rise on U.S. Retail Pharmacy Segment Growth
07:49am, Tuesday, 08'th Apr 2025
Walgreens Boots Alliance posted higher sales in its latest quarter on growth in retail-pharmacy sales in the U.S., in one of the last quarterly reports the company will publicly file ahead of its tran
